Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTION 2
NCT04375878Phase 2Completed
- Sponsor
- Entero Therapeutics, Inc.
- Start
- Jul 2020
- Primary completion
- Apr 2021
- Modality
- Replacement Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of adrulipase alfa in exocrine pancreatic insufficiency (EPI), sponsored by Entero Therapeutics, Inc.. Started Jul 2020; status: completed.
02
Drugs
adrulipase alfa
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT04375878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04375878.